Teva Branded Pharmaceutical Products R&d Llc

This study tests an experimental pill called TEV-56286 for people with multiple system atrophy (MSA), a rare and serious brain disorder that affects movement and body functions. The trial will include 350 adults and last about 56 weeks. Researchers want to see if the drug can slo…

This early-phase trial tests a new drug, TEV-56278, alone or with pembrolizumab, in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 240 adul…

This study tests whether a new inhaler that combines a steroid (fluticasone) with a rescue medicine (albuterol) can prevent severe asthma attacks better than albuterol alone. About 2,700 adults with asthma who have had at least one severe attack in the past year will take part. T…